The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,843
Carpenter, G., & Cohen, S. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001205 · Cited by 2,909
Karlin, S., & Altschul, S. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2264 · Cited by 1,535
Requirement for neuregulin receptor erbB2 in neural and cardiac development
Lee, K.-F., Simon, H., Chen, H., Bates, B., Hung, M.-C., & Hauser, C. (1995) · Nature · doi:10.1038/378394a0 · Cited by 1,290
Multiple essential functions of neuregulin in development
Meyer, D., & Birchmeier, C. (1995) · Nature · doi:10.1038/378386a0 · Cited by 1,262
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., & Lemke, G. (1995) · Nature · doi:10.1038/378390a0 · Cited by 1,148
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., & Klagsbrun, M. (1991) · Science · doi:10.1126/science.1840698 · Cited by 1,127 · cited 2×
“In addition to NRG-1, NRG-2, and NRG-3, ErbB-4 also binds to betacellulin (Riese et al., 1996a), epiregulin (Shelly et al., 1998) and HB-EGF (Elenius et al., 1997).”
BackgroundTzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., & Yarden, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5276 · Cited by 1,036
Self-citationIdentification of Heregulin, a Specific Activator of p185 erbB2
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) · Science · doi:10.1126/science.256.5060.1205 · Cited by 962
Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00603.x · Cited by 769
Self-citationGlial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system
Marchionni, M. A., Goodearl, A. D. J., Su Chen, M., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., et al. (1993) · Nature · doi:10.1038/362312a0 · Cited by 738
Severe neuropathies in mice with targeted mutations in the ErbB3 receptor
Riethmacher, D., Sonnenberg-Riethmacher, E., Brinkmann, V., Yamaai, T., Lewin, G. R., & Birchmeier, C. (1997) · Nature · doi:10.1038/39593 · Cited by 729
Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., & Shoyab, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 713
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8132 · Cited by 698 · cited 1×
“In contrast to possible homodimer formation of ErbB-1 and ErbB-4, for ErbB-2, which has no known direct ligand, and for ErbB-3, which lacks an intrinsic tyrosine kinase activity (Guy et al., 1994), homodimers either do not form or are inactive.”
BackgroundSmith, T. F., & Waterman, M. S. (1981) · Advances in Applied Mathematics · doi:10.1016/0196-8858(81)90046-4 · Cited by 677
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Seger, R., Hynes, N. E., & Yarden, Y. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00356.x · Cited by 674
Self-citationRat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor
Marquardt, H., Hunkapiller, M. W., Hood, L. E., & Todaro, G. J. (1984) · Science · doi:10.1126/science.6320373 · Cited by 666
MEMBRANE-ANCHORED GROWTH FACTORS
Massagué, J., & Pandiella, A. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002503 · Cited by 660
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., & Carraway, K. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36676-0 · Cited by 643
Structure and Function of Human Amphiregulin: A Member of the Epidermal Growth Factor Family
Shoyab, M., Plowman, G. D., McDonald, V. L., Bradley, J. G., & Todaro, G. J. (1989) · Science · doi:10.1126/science.2466334 · Cited by 597
Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90456-m · Cited by 577
Self-citationTam, J. P., Heath, W. F., & Merrifield, R. B. (1983) · Journal of the American Chemical Society · doi:10.1021/ja00359a014 · Cited by 545
Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B., & Yarden, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90131-u · Cited by 524 · cited 1×
“NRG-1 (also named Neu di erentiation factor (NDF), heregulin, glial growth factor, and acetylcholine receptor inducing activity) was ®rst identi®ed by its ability to indirectly phosphorylate ErbB-2 (Holmes et al., 1992; Peles et al., 1992; Wen et al., 1992).”
BackgroundSelf-citationNeuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis
Burden, S., & Yarden, Y. (1997) · Neuron · doi:10.1016/s0896-6273(00)80324-4 · Cited by 476
Self-citationErickson, S. L., O’Shea, K. S., Ghaboosi, N., Loverro, L., Frantz, G., Bauer, M., Lu, L. H., & Moore, M. W. (1997) · Development · doi:10.1242/dev.124.24.4999 · Cited by 467
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
Carraway III, K. L., Weber, J. L., Unger, M. J., Ledesma, J., Yu, N., Gassmann, M., & Lai, C. (1997) · Nature · doi:10.1038/387512a0 · Cited by 394
Betacellulin: a mitogen from pancreatic beta cell tumors
Shing, Y., Christofori, G., Hanahan, D., Ono, Y., Sasada, R., Igarashi, K., & Folkman, J. (1993) · Science · doi:10.1126/science.8456283 · Cited by 393
Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4
Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J., & Godowski, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9562 · Cited by 383
The Cellular Response to Neuregulins Is Governed by Complex Interactions of the erbB Receptor Family
Riese, D. J., van Raaij, T. M., Plowman, G. D., Andrews, G. C., & Stern, D. F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5770 · Cited by 368
Self-citationElenius, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1268 · Cited by 343
Graus-Porta, D., Beerli, R. R., & Hynes, N. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1182 · Cited by 296
Ligands for ErbB-family receptors encoded by a neuregulin-like gene
Chang, H., Riese II, D. J., Gilbert, W., Stern, D. F., & McMahan, U. J. (1997) · Nature · doi:10.1038/387509a0 · Cited by 281
Tzahar, E., Levkowitz, G., Karunagaran, D., Yi, L., Peles, E., Lavi, S., Chang, D., Liu, N., Yayon, A., & Wen, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31521-1 · Cited by 272
Self-citationIsobe, T., Okuyama, T., Toyoda, H., Komurasaki, T., Uchida, D., Takayama, Y., & Hanada, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7495 · Cited by 269 · cited 1×
“One category, the ErbB-1 ligands, includes EGF, transforming growth factor a (TGFa), epiregulin, amphiregulin, betacellulin and the heparin-binding EGF (HB-EGF) (Higashiyama et al., 1991; Marquardt et al., 1984; Shing et al., 1993; Shoyab et al., 1989; Toyoda et al., 1995).”
BackgroundStructural and functional aspects of the multiplicity of Neu differentiation factors.
Wen, D., Suggs, S. V., Karunagaran, D., Liu, N., Cupples, R. L., Luo, Y., Janssen, A. M., Ben-Baruch, N., Trollinger, D. B., & Jacobsen, V. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1909 · Cited by 234
Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., & Yarden, Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05737.x · Cited by 233
Self-citationBivalence of EGF-like ligands drives the ErbB signaling network
Tzahar, E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4938 · Cited by 228
Self-citationThe ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands
Tzahar, E. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00032-2 · Cited by 191
Self-citationKlapper, L. N., Vaisman, N., Hurwitz, E., Pinkas-Kramarski, R., Yarden, Y., & Sela, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201029 · Cited by 174
Self-citationRiese, D. J., Kim, E. D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G. D., & Stern, D. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20047 · Cited by 166
Shelly, M., Pinkas-Kramarski, R., Guarino, B. C., Waterman, H., Wang, L.-M., Lyass, L., Alimandi, M., Kuo, A., Bacus, S. S., Pierce, J. H., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10496 · Cited by 161
Self-citationErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network
Pinkas‐Kramarski, R., Shelly, M., Guarino, B. C., Wang, L. M., Lyass, L., Alroy, I., Alamandi, M., Kuo, A. H., Moyer, J. D., Lavi, S., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.6090 · Cited by 145
Self-citationAlimandi, M., Wang, L., Bottaro, D. P., Lee, C., Kuo, A. H., Frankel, M. E., Fedi, P., Tang, C. K., Lippman, M. E., & Pierce, J. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5608 · Cited by 132
Self-citationDetection of ERK activation by a novel monoclonal antibody
Yung, Y., Dolginov, Y., Yao, Z., Rubinfeld, H., Michael, D., Hanoch, T., Roubini, E., Lando, Z., Zharhary, D., & Seger, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00442-0 · Cited by 131
Pinkas‐Kramarski, R., Eilam, R., Alroy, I., Levkowitz, G., Lonai, P., & Yarden, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1201466 · Cited by 130
Self-citationChen, X., Levkowitz, G., Tzahar, E., Karunagaran, D., Lavi, S., Ben-Baruch, N. E., Leitner, O., Ratzkin, B. J., Bacus, S. S., & Yarden, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7620 · Cited by 128
Self-citationCohen, B. D., Kiener, P. A., Green, J. M., Foy, L., Fell, H. P., & Zhang, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30897 · Cited by 125
Busfield, S. J., Michnick, D., Chickering, T. W., Revett, T., Ma, J., Woolf, E. A., Comrack, C. A., Dussault, B. J., Woolf, J., Goodearl, A. D. J., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4007 · Cited by 118
Engineering epidermal growth factor for enhanced mitogenic potency
Reddy, C. C., Niyogi, S. K., Wells, A. H., Wiley, H. S., & Lauffenburger, D. A. (1996) · Nature Biotechnology · doi:10.1038/nbt1296-1696 · Cited by 105
Wang, L.-M., Kuo, A. H., Alimandi, M., Veri, M. C., Lee, C.-C., Kapoor, V., Ellmore, N., Chen, X.-H., & Pierce, J. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6809 · Cited by 99
Self-citationThe Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding
Barbacci-Tobin, E. G., Guarino, B. C., Stroh, J. G., Singleton, D. H., Rosnack, K. J., Moyer, J. D., & Andrews, G. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9585 · Cited by 95
Self-citationNeu Differentiation Factor Inhibits EGF Binding
Karunagaran, D., Tzahar, E., Liu, N., Wen, D., & Yarden, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9982 · Cited by 60
Self-citationJones, J. T., Ballinger, M. D., Pisacane, P. I., Lofgren, J. A., Fitzpatrick, V. D., Fairbrother, W. J., Wells, J. A., & Sliwkowski, M. X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11667 · Cited by 57
Chan, S. D. H., Antoniucci, D. M., Fok, K. S., Alajoki, M. L., Harkins, R. N., Thompson, S. A., & Wada, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22608 · Cited by 47
Cited by
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Epidermal growth factor receptor (EGFR) signaling in cancer
Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006) · Gene · doi:10.1016/j.gene.2005.10.018 · Cited by 2,038
Epidermal growth factor receptor: Mechanisms of activation and signalling
Jorissen, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00098-8 · Cited by 1,565
The EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Neuregulins: functions, forms, and signaling strategies
Falls, D. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00102-7 · Cited by 1,071
Metadata
- Authors
- Harari, D., Tzahar, E., Romano, J., Shelly, M., Pierce, J., Andrews, G., & Yarden, Y.
- Venue
- Oncogene
- Published
- 1999-04-28
- Volume
- 18
- Issue
- 17
- Pages
- 2681-2689
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2315705156
- Cited by
- 318
- References
- 55
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.